BioCardia prices $6M public offering of 4.8M shares and warrants; up to $6M more from warrant exercise

BioCardia, Inc.

Public offering of 4,800,000 shares and short-term warrants for 4,800,000 shares at $1.25 per unit.
Gross proceeds of $6 million upfront; potential additional $6 million if warrants fully exercised on cash basis.
Short-term warrants exercisable at $1.25 per share, expire two years from issuance.
Closing expected September 19, 2025; H.C. Wainwright acting as exclusive placement agent.
Net proceeds to be used for working capital, advancing biotherapeutic candidates and delivery partnership business.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.